血管性痴呆患者血清炎症因子和生化指标的检测及临床意义

doi:10.3969/j.issn.1006-6233.2018.03.046

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1325 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the clinical significance of detecting serum inflammatory factors and biochemical indexes in patients with vascular dementia (VD) so as to provide reference for the clinical diagnosis of patients with this disease. Methods: 82 patients with vascular dementia (observation group) admitted to our hospital from October 2012 to October 2016 and 85 normal persons (control group) who underwent health examination in our hospital during the same period were enrolled in this study. Serum levels of inflammatory cytokines and life indicators, analysis of the two groups were included in the indicators of the differences between the levels. Results: The levels of IL-1β, TNF-α and IL-6 in the observation group were [(62.69 ± 31.08) pg / mL], [(8.41 ± 2.06) foml / mL] and [(10.97 ± 5.12) pg / mL] were significantly higher in the control group than those in the control group (P <0.05) The levels of Hcy, HDL-C, LDL-C, triglyceride and apolipoprotein A were [(37.51 ± 19.34) umoL / L, 0.90 ± 0.23 nmoL / L, 3.14 ± 1.11 nmoL / L, 1.74 ± 1.02 mmoL / L, / L], there was significant difference between each index level and the control group (P <0.05). There was no significant difference in the levels of other inflammatory factors and biochemical indexes between the two groups (P> 0.05). Conclusion: There are differences in inflammatory factors and biochemical indicators between vascular dementia patients and normal persons. Joint detection of inflammatory factors and biochemical indicators is helpful for clinical diagnosis of vascular dementia patients.

Key words： Vascular dementia Inflammatory factors Biochemical indexes

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2018.03.046 OR http://www.hbyxzzs.cn/EN/Y2018/V24/I3/517

[1] 王凌星,黄红红,易继铭.普罗布考辅治对血管性痴呆患者血清炎症因子及氧化应激指标的影响[J].白求恩医学杂志,2017,15(4):480~481,506.
[2] Doruk H, Naharci M I, Bozoglu E, et al. The relationship between body mass index and incidental mild cognitive impairment, Alzheimer's disease and vascular dementia in elderly[J].Nutr Health Aging,2010, 14(10): 834~838.
[3] Yang X N, Li C S, Chen C, et al. Protective effect of shouwuyizhi decoction against vascular dementia by promoting angiogenesis[J]. Chin Nat Med,2017, 15(10): 740~750.
[4] 杨雪霞.血管性痴呆与帕金森病痴呆患者认知功能及抑郁状况比较[J].重庆医学,2014,43(21):2794~2796.
[5] 丁彬彬,邬建民,介勇,等.阿尔茨海默病和血管性痴呆患者血清炎症因子和生化指标的检测及临床意义[J].检验医学,2016,31(5):363~367.
[6] Dong J, Zhao J, Lin Y, et al. Exercise improves recognition memory and synaptic plasticity in the prefrontal cortex for rats modelling vascular dementia[J]. Neurol Res,2017: 1~10.
[7] 欧阳基鹏,何慧君,李艳.依那普利叶酸片与依那普利片治疗血管性痴呆伴H型高血压的疗效比较[J].广东医学,2014,35(15):2444~2445.
[8] 刘莲艾,徐进,徐燕芝,等.早期血管性痴呆患者的效应连接研究[J].西安交通大学学报,2016,50(3):146~150.
[9] 郭强,赵欢,杨东东,等.中西医结合治疗血管性痴呆的系统评价[J].中国老年学杂志,2016,36(2):339~342.
[10] Yun H J, Moon S H, Kim H J, et al. Centiloid method evaluation for amyloid PET of subcortical vascular dementia[J]. Sci Rep,2017, 7(1): 16322.
[11] 杨申,梁迎春,颜秀梅,等.丁苯酞对血管性痴呆大鼠认知功能及海马细胞凋亡、磷酸化p38MAPK表达的影响[J].中华行为医学与脑科学杂志,2014,23(4):300~302.
[12] Choi D H, Lee J. A Mini-Review of the NADPH oxidases in vascular dementia: correlation with NOXs and risk factors for VaD[J]. Int Mol Sci,2017, 18(11).